Daniel Kracov
Co-chair at Arnold & Porter’s global Life Sciences and Healthcare Regulatory practice
Dan Kracov is co-chair of Arnold & Porter’s global Life Sciences and Healthcare Regulatory practice. For decades, he has been one of the foremost Food and Drug Administration lawyers in the country, and his expertise in critical regulatory matters has been widely recognized by Chambers, the Legal Times, Best Lawyers in America, and other publications. LMG Life Sciences recently named him the 2020 Pharmaceutical Regulatory Attorney of the Year. A particular focus of his practice is assisting pharmaceutical, biotechnology, and medical device companies in negotiating challenges relating to the development, approval and marketing of FDA-regulated products. In addition to day-to-day counseling on regulatory strategies and concerns, Mr. Kracov regularly handles product and compliance-related government and internal investigations and enforcement, the development of global corporate compliance programs, and due diligence in financings, mergers and acquisitions. He has a widely recognized experience in biomedical public policy matters, including Congressional investigations and advising on FDA-related legislation.